Barber Daniel

President and CEO

Barber Daniel has filed 9 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.

On the most recent filing, Barber Daniel is listed as President and CEO at Aquestive Therapeutics, Inc. Inside the rolling window, Barber Daniel reported no open-market purchases and 7 open-market sales totaling $1.2M in AQST. The largest disclosed transaction in the window is a sale of 180,677 AQST shares on Mar 10, 2026, worth $754K.

Companies traded

Other insiders at AQST

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
AQSTSale$106KOct 16SEC ↗
AQSTSale$120KSep 16SEC ↗
AQSTSale$107KAug 18SEC ↗
AQSTSale$19KJul 17SEC ↗
AQSTSale$82KJul 17SEC ↗
AQSTSale$35KMay 18SEC ↗
AQSTSale$754KMar 11SEC ↗
Showing 1–7 of 7
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 26, 2025AQSTSale$551K
Sep 19, 2025AQSTSale$2K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Barber Daniel made?

Barber Daniel has filed 9 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does Barber Daniel trade?

Barber Daniel has filed SEC Form 4 disclosures for 1 company, including AQST.

When was Barber Daniel's most recent SEC Form 4 filing?

Barber Daniel's most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.

What is Barber Daniel's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Barber Daniel is listed as President and CEO.

What is Barber Daniel's total buy and sell value in the current window?

Inside the rolling retention window, Barber Daniel bought $0 and sold $1.2M based on SEC Form 4 filings.

What was Barber Daniel's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 180,677 AQST shares on 2026-03-10, worth $754K, per SEC Form 4 filings.